Literature DB >> 1775591

To increase power in randomized clinical trials without increasing sample size.

H C Kraemer1.   

Abstract

The power of a randomized clinical trial (RCT) depends on two factors: sample size and effect size. Most psychiatric research design strategies focus on increasing sample size, despite major problems in recruiting large numbers of subjects or funding such costly studies. It is possible to increase power in RCTs in a variety of ways without increasing sample size, in essence by increasing effect size by decreasing within-group variance. Such strategies are presented and discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1775591

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  17 in total

Review 1.  Sample size estimation in research with dependent measures and dichotomous outcomes.

Authors:  Kevin L Delucchi
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

Review 2.  Optimising the economic efficiency of drug studies.

Authors:  M E Kitler
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

Review 3.  Medication screening for smoking cessation: a proposal for new methodologies.

Authors:  Kenneth A Perkins; Maxine Stitzer; Caryn Lerman
Journal:  Psychopharmacology (Berl)       Date:  2005-09-15       Impact factor: 4.530

4.  The role of behavior observation in measurement systems for randomized prevention trials.

Authors:  James Snyder; John Reid; Mike Stoolmiller; George Howe; Hendricks Brown; Getachew Dagne; Wendi Cross
Journal:  Prev Sci       Date:  2006-03

Review 5.  DSM categories and dimensions in clinical and research contexts.

Authors:  Helena Chmura Kraemer
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

Review 6.  The analysis of intervention change in children and families: methodological and conceptual issues embedded in intervention studies.

Authors:  J M Eddy; T J Dishion; M Stoolmiller
Journal:  J Abnorm Child Psychol       Date:  1998-02

Review 7.  Essential statistical principles of clinical trials of pain treatments.

Authors:  Robert H Dworkin; Scott R Evans; Omar Mbowe; Michael P McDermott
Journal:  Pain Rep       Date:  2020-12-18

8.  More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments.

Authors:  J F Fries; B Bruce; J Bjorner; M Rose
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

9.  Evaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): A randomized controlled trial.

Authors:  Lisa G Rosas; Nan Lv; Lan Xiao; Megan A Lewis; Patricia Zavella; M Kaye Kramer; Veronica Luna; Jun Ma
Journal:  Contemp Clin Trials       Date:  2016-03-16       Impact factor: 2.226

10.  What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it?

Authors:  Aaron S Kemp; Nina R Schooler; Amir H Kalali; Larry Alphs; Ravi Anand; George Awad; Michael Davidson; Sanjay Dubé; Larry Ereshefsky; Georges Gharabawi; Andrew C Leon; Jean-Pierre Lepine; Steven G Potkin; An Vermeulen
Journal:  Schizophr Bull       Date:  2008-08-22       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.